Markets
Organigram moves to buy Aurora for C$561M as Curaleaf keeps its hostile bid alive
A friendly all-Canadian deal at C$7.80 a share now competes with Curaleaf's amended hostile bid, and Aurora's board has picked a side.
Markets
Markets
SNDL books record free cash flow while it reviews its grow business
Cannabis retail held up; production shrank after the company quit unprofitable domestic flower and took a C$52 million write-down.